BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Capsida Biotherapeutics Announces Strategic Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Develop Non-Invasive Gene Therapies for CNS Diseases

  Capsida Biotherapeutics Inc. (“Capsida”) today announced a multi-year strategic collaboration with Prevail Therapeutics (“Prevail”), a wholly owned subsidiary of Eli Lilly and Company (“Lilly”), to develop transformative genetic medicines for serious diseases.

  January 4, 2023

   · 

  4 min read
• Business

  CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability

  CHARM Therapeutics today announces the expansion of its leadership team with a series of key appointments to strengthen its drug discovery and development, as well as operational management capabilities.

  January 4, 2023

   · 

  5 min read
• Genetown

  Atea Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

  Atea Pharmaceuticals, Inc. today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals, will present a business update at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 3:00 p.m. PT in San Francisco, CA.

  January 4, 2023

   · 

  3 min read
• Bio NC

  Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference

  Bioventus Inc. today announced that Ken Reali, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 5:15 p.m. PT (8:15 p.m. ET).

  January 4, 2023

   · 

  1 min read
• Genetown

  Voyager Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

  Voyager Therapeutics, Inc. today announced that CEO Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 10:30 a.m. PT / 1:30 p.m. ET.

  January 4, 2023

   · 

  1 min read
• Business

  Kymera Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary

  Kymera Therapeutics, Inc. today announced the appointment of Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary.

  January 4, 2023

   · 

  3 min read
• Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference

  Axogen, Inc. today announced that Karen Zaderej, chairman, CEO, and president, will present at the JP Morgan 41st Annual Healthcare Conference in San Francisco.

  January 4, 2023

   · 

  2 min read
• Drug Development

  Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009

  Immunitas Therapeutics today announced the first patient has been dosed in a Phase 1/2a clinical trial evaluating use of novel cancer immunotherapeutic IMT-009 in solid tumors and hematologic malignancies.

  January 4, 2023

   · 

  4 min read
• Genetown

  Syndax Announces Presentation at 41st Annual J.P. Morgan Healthcare Conference

  Syndax Pharmaceuticals, Inc. announced that Michael A. Metzger, Chief Executive Officer of Syndax, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 10:30 a.m. PT/ 1:30 p.m. ET.

  January 4, 2023

   · 

  1 min read
• Biotech Bay

  Kodiak Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

  Kodiak Sciences Inc. announced today that management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2023, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time).

  January 4, 2023

   · 

  2 min read